Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically engineered vaccines: problems and promises.

F Brown1, G Dougan, D Snary

  • 1Wellcome Biotechnology Limited, Beckenham, Kent, UK.

Microbiological Sciences
|August 1, 1984
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study.

International journal of colorectal disease·2005
Same author

Crystallization of an antitumour antibody SM3 complexed with a peptide epitope.

Acta crystallographica. Section D, Biological crystallography·2004
Same author

Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge.

Journal of virology·2003
Same author

Broad-spectrum virus reduction in red cell concentrates using INACTINE PEN110 chemistry.

Vox sanguinis·2002
Same author

Synthetic peptide-based vaccine and diagnostic system for effective control of FMD.

Biologicals : journal of the International Association of Biological Standardization·2002
Same author

Inpatient diagnostic assessments: 1. Accuracy of structured vs. unstructured interviews.

Psychiatry research·2002
Same journal

Fungal cell wall synthesis: the construction of a biological structure.

Microbiological sciences·1988
Same journal

Microbial digestion of hemicelluloses in the rumen.

Microbiological sciences·1988
Same journal

Assessing the risks of releasing recombinant Streptomyces in soil.

Microbiological sciences·1988
Same journal

Outbreaks of listeriosis/Listeria-contaminated foods.

Microbiological sciences·1988
Same journal

Virus-induced diseases of the eye: the role of herpesviruses in retinitis.

Microbiological sciences·1988
Same journal

Epstein-Barr virus and the chronic fatigue syndrome: a short review.

Microbiological sciences·1988
See all related articles

Recombinant DNA technology enables cloning and expression of pathogen antigens for novel vaccine development. This includes subunit, live attenuated, and synthetic peptide vaccines against viral, bacterial, and parasite threats.

Area of Science:

  • Molecular biology
  • Vaccinology
  • Immunology

Background:

  • Protective antigens are crucial for vaccine design.
  • Recombinant DNA technology offers a powerful tool for antigen production.

Purpose of the Study:

  • To describe the cloning and expression of protective antigens from various pathogens.
  • To outline the application of these antigens in developing novel vaccine strategies.

Main Methods:

  • Utilizing recombinant DNA techniques to clone and express pathogen antigen determinants.
  • Employing novel host systems for antigen expression.

Main Results:

  • Successful cloning and expression of protective antigen determinants from viral, bacterial, and parasite pathogens.

Related Experiment Videos

  • Demonstrated feasibility of using these expressed antigens in vaccine development.

    • Conclusions:

    • Recombinant DNA technology is effective for producing key vaccine components.
    • This approach facilitates the creation of diverse vaccine types, including subunit, live attenuated, and synthetic peptide vaccines.